At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels
In Brief
A Phase 1 clinical trial evaluating Low dose testosterone nasal gel, single dose, Medium dose testosterone nasal gel, single dose, and 2 other interventions for Female Sexual Dysfunction. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of this study was to assess the bioavailability of total testosterone through pharmacokinetic profiles obtained following (a) single administration of three doses of TBS-2 b) multiple administration TBS-2. In addition, assessing the bioavailability of free testosterone, dihydrotestosterone, SHBG and estradiol through pharmacokinetic profiles was also conducted.
Study Details
Timeline
Interventions
Low dose testosterone nasal gel, single dose
Medium dose testosterone nasal gel, single dose
High dose testosterone nasal gel, single dose
Medium dose testosterone nasal gel, multiple dose